Categories: News

SutheDermal.com Launches: Revolutionizing Comfort in Self-Injection Therapies

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Revolutionary vibration device offers pain relief for finger pricks, GLP-1 shots, and wellness injections

BOCA RATON, Fla., April 22, 2025 /PRNewswire/ — Suthe is proud to announce the launch of its new website, SutheDermal.com, introducing DigiVibe™—a groundbreaking device designed to alleviate the discomfort and anxiety associated with self-injections and finger pricking.

With the rising prevalence of injectable treatments for conditions like diabetes, fertility protocols & weight management, SutheDermal.com addresses a critical need for a more comfortable patient experience. DigiVibe™ employs advanced vibration technology to minimize pain perception, making self-injection more manageable for users.

The newly launched website offers:

  • User-Centric Design: An intuitive interface that guides users through product information and purchasing options.
  • Educational Resources: Comprehensive guides and FAQs to assist users in understanding and utilizing DigiVibe™ effectively.
  • Secure E-Commerce Platform: A streamlined shopping experience with robust security measures to protect customer information.  

“Our mission is to enhance the quality of life for individuals requiring regular injections by providing innovative solutions that reduce discomfort and anxiety,” said Mark Lorberbaum, Founder & CEO at Suthe.

For more information, visit https://suthedermal.com.

Media Contact:
Terri Previte, Director of Digital Marketing
Mark Lorberbaum, Founder & CEO
***@suthedermal.com
(844) 503-8423

Photos:
https://www.prlog.org/13072799

Press release distributed by PRLog

View original content:https://www.prnewswire.com/news-releases/suthedermalcom-launches-revolutionizing-comfort-in-self-injection-therapies-302435113.html

SOURCE Digivibe by Suthe

Staff

Recent Posts

GE HealthCare drives innovation in theranostics with latest technological advances

GE HealthCare is helping advance clinical and operational excellence in theranostics and molecular imaging through…

4 hours ago

Saudi Arabia Concludes Landmark BIO 2025 Debut as Kingdom Opens Doors to Global Biotech Collaboration

From genomics to regulatory innovation, the Kingdom’s presence in Boston establishes it as a major…

4 hours ago

Enzon and Viskase Enter into Merger Agreement

Enzon and Viskase stockholders will respectively own approximately 15.9% and 84.1% of the combined companyCRANFORD,…

4 hours ago

Novo Nordisk’s subcutaneous and oral amycretin data published in The Lancet and presented at ADA 2025

Subcutaneous amycretin phase 1b/2a data on the safety, tolerability and weight loss potential in people…

4 hours ago